'I don't think I'd be frightened if the statins went': A phenomenological qualitative study exploring medicines use in palliative care patients, carers and healthcare professionals.

BMC Palliative Care

Volumn 15, Issue 1, 2016, Pages

  Todd, Adam ^a   Holmes, Holly ^b   Pearson, Sallie ^c   Hughes, Carmel ^d   Andrew, Inga ^e   Baker, Lisa ^e   Husband, Andy ^a  

^a DURHAM UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e Centre for Specialist Palliative Care   (United Kingdom)

Author keywords

Deprescribing; Palliative care; Phenomenology; Polypharmacy

Indexed keywords

ATENOLOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LISINOPRIL;

ADULT; AGED; ARTICLE; ATTITUDE TO ILLNESS; CAREGIVER; CLINICAL ARTICLE; DEPRESCRIPTION; DRUG SAFETY; DRUG USE; FEMALE; HEALTH BEHAVIOR; HEALTH PERSONNEL ATTITUDE; HUMAN; LIFE EXPECTANCY; MALE; PALLIATIVE THERAPY; PATIENT ATTITUDE; PHENOMENOLOGY; QUALITATIVE RESEARCH; TERMINAL DISEASE; VERY ELDERLY; DAILY LIFE ACTIVITY; HEALTH CARE PERSONNEL; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; PATIENT; POLYPHARMACY; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; CAREGIVERS; FEMALE; HEALTH PERSONNEL; HUMANS; MALE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; PALLIATIVE CARE; PATIENTS; POLYPHARMACY; QUALITATIVE RESEARCH; QUALITY OF LIFE;

EID: 84956921428     PISSN: None     EISSN: 1472684X     Source Type: Journal    
DOI: 10.1186/s12904-016-0086-7     Document Type: Article

References (27)

1. Hall S, Petkova H, Tsouros AD, Costantini M, Higginson IJ. Palliative care for older people: better practices. World Health Organisation. 2011. Available at: http://www.euro.who.int/-data/assets/pdf-file/0017/143153/e95052.pdf. Accessed 14 Oct 2015.
2. Stjernswärd J, Foley KM, Ferris FD. The public health strategy for palliative care. J Pain Symptom Manage. 2007;33(5):486-93.
3. Todd A, Nazar H, Pearson H, Andrew L, Baker L, Husband A. Inappropriate prescribing in patients accessing specialist palliative day care services. Int J Clin Pharm. 2014;36(3):535-43.
4. Todd A, Williamson S, Husband A, Baqir W, Mahony M. Patients with advanced lung cancer: is there scope to discontinue inappropriate medication? Int J Clin Pharm. 2013;35:181-4.
5. Tjia J, Briesacher BA, Peterson D, Liu Q, Andrade SE, Mitchell SL. Use of medications of questionable benefit in advanced dementia. JAMA Intern Med. 2014;174(11):1763-71.
6. Todd A, Husband A, Andrew I, Pearson S, Lindsey L, Holmes H. Inappropriate prescribing of preventative medication in patients with life-limiting illness: a systematic review. BMJ Support Palliat Care. 2016. doi: 10.1136/bmjspcare-2015-000941.
7. Kotlinska-Lemieszek A, Paulsen O, Kaasa S, et al. Polypharmacy in patients with advanced cancer and pain: a european cross-sectional study of 2282 patients. J Pain Symptom Manage. 2014;48(6):1145-59.
8. Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015. doi: 10.1001/jamainternmed.2015.0324.
9. Lindsay J, Dooley M, Martin J, Fay M, Kearney A, Khatun M, et al. The development and evaluation of an oncological palliative care deprescribing guideline: the 'OncPal deprescribing guideline'. Support Care Cancer. 2015;23(1):71-8.
10. Husserl E. The crisis of European sciences and transcendental phenomenology. Evanston: Northwest University Press; 1970.
11. Van Manen M. Researching the lived experience: human science for an action sensitive pedagogy. Albany: State University of New York Press; 1990.
12. Close H. The use of photography as a qualitative research tool. Nurse Res. 2007;15(1):27-36.
13. Harper D. Talking about pictures: a case for photo elicitation. Vis Stud. 2002;17:13-26.
14. Cresswell JW. Qualitative inquiry and research design: choosing among five approaches. 2nd ed. London: Sage Publications; 2006.
15. Murray SA, Boyd K, Kendall M, Worth A, Benton TF, Clausen H. Dying of lung cancer or cardiac failure: prospective qualitative interview study of patients and their carers in the community. BMJ. 2002;325(7370):929.
16. Sand AM, Harris J, Rosland JH. Living with advanced cancer and short life expectancy: patients' experiences with managing medication. J Palliat Care. 2009;25(2):85-91.
17. Qi K, Reeve E, Hilmer SN, Pearson SA, Matthews S, Gnjidic D. Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia. Int J Clin Pharm. 2015. doi: 10.1007/s11096-015-0147-7.
18. McKechnie R, MacLeod R, Keeling S. Facing uncertainty: the lived experience of palliative care. Palliat Support Care. 2007;5(3):255-64.
19. Tjia J, Ellington L, Clayton MF, Lemay C, Reblin M. Managing medications during home hospice cancer care: the needs of family caregivers. J Pain Symptom Manage. 2015. doi: 10.1016/j.jpainsymman.2015.06.005.
20. Lau DT, Kasper JD, Hauser JM, Berdes C, Chang CH, Berman RL, et al. Family caregiver skills in medication management for hospice patients: a qualitative study to define a construct. J Gerontol B Psychol Sci Soc Sci. 2009;64:799e807.
21. Kutner JS, Blatchford PJ, Taylor Jr DH, Ritchie CS, Bull JH, Fairclough DL, et al. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. JAMA Intern Med. 2015. doi: 10.1001/jamainternmed.2015.0289.
22. Todd A, Holmes HM. Recommendations to support deprescribing medications late in life. Int J Clin Pharm. 10.1007/s11096-015-0148-6.
23. Anderson K, Stowasser D, Freeman C, Scott I. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4(12), e006544. doi: 10.1136/bmjopen-2014-006544.
24. Schuling J, Gebben H, Veehof LJ, Haaijer-Ruskamp FM. Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study. BMC Fam Pract. 2012;13:56.
25. Haddow G. The phenomenology of death, embodiment and organ transplantation. Sociol Health Illn. 2005;27(1):92-113.
26. Miller C, Jezewski MA. A phenomenologic assessment of relapsing MS patients' experiences during treatment with interferon beta-1a. J Neurosci Nurs. 2001;33(5):240-4.
27. Burton CR. Living with stroke: a phenomenological study. J Adv Nurs. 2000;32(2):301-9.